NOVARTIS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.35 CHF | +0.38% |
|
+2.36% | +12.37% |
ETFs positioned on Novartis AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.51% | 23 M€ | -.--% | - | |
| 0.50% | 206 M€ | -.--% | ||
| 0.48% | 205 M€ | -.--% | ||
| 0.47% | 727 M€ | +8.16% | ||
| 0.39% | 283 M€ | +21.58% | ||
| 0.37% | 1,166 M€ | +0.26% | - | |
| 0.37% | 607 M€ | +0.05% | - | |
| 0.30% | 36 M€ | +2.79% | - | |
| 0.26% | 391 M€ | +9.83% | - | |
| 0.23% | 34 M€ | +9.40% | - | |
| 0.22% | 0 M€ | 0.00% | - | |
| 0.21% | 45 M€ | 0.00% | - | |
| 0.17% | 306 M€ | +6.74% | - | |
| 0.17% | 39 M€ | +6.61% | - | |
| 0.13% | 105 M€ | +4.21% | - | |
| 0.12% | 17 M€ | +3.78% | - | |
| 0.09% | 34 M€ | +4.23% | - | |
| 0.08% | 234 M€ | +11.44% | - | |
| 0.06% | 54 M€ | +1.25% | - | |
| 0.06% | 8 M€ | +1.54% | - |
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:
- oncology (29.9%);
- immunology (17.2%);
- cardiovascular, renal and metabolic diseases (14.1%);
- neuroscience (8.9%).
The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.
At the end of 2023, Novartis AG had 33 production sites worldwide.
Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
Pharmaceuticals
Calendar
2024-06-18
- Citi European Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.5
USD
Average target price
110.2
USD
Spread / Average Target
+3.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.37% | 217B | |
| +43.64% | 754B | |
| +40.19% | 630B | |
| -6.58% | 352B | |
| +19.72% | 331B | |
| +8.78% | 298B | |
| +18.47% | 250B | |
| -0.41% | 216B | |
| +6.13% | 164B | |
| +0.03% | 163B |
- Stock Market
- Equities
- NOVN Stock
- Funds and ETFs Novartis AG
